LP
Leerink Partners Latest Price Targets & Analyst Ratings
| Stock | Analyst | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|---|
26
Insmed
INSM
$30.7B
|
JS
Joseph Schwartz
| $145.10 | $115 |
21%
downside
| Outperform | 2 months ago |
|
27
Arvinas
ARVN
$575M
|
AB
Andrew Berens
| $7.83 | $9 |
15%
upside
| Market Perform | 3 months ago |
|
28
Rocket Pharmaceuticals
RCKT
$354M
|
MF
Mani Foroohar
| $3.28 | $8 |
144%
upside
| Market Perform | 3 months ago |
|
29
Fulcrum Therapeutics
FULC
$414M
|
JS
Joseph Schwartz
| $7.66 | $12 |
57%
upside
| Outperform | 3 months ago |
|
30
Halozyme
HALO
$8.76B
| $74.93 | $47 |
37%
downside
| Underperform | 3 months ago |
|
|
31
Johnson & Johnson
JNJ
$430B
|
DR
David Risinger
| $178.43 | $153 |
14%
downside
| Market Perform | 3 months ago |
|
32
Amylyx Pharmaceuticals
AMLX
$910M
|
MG
Marc Goodman
| $10.20 | $10 |
2%
downside
| Outperform | 4 months ago |
|
33
Vertex Pharmaceuticals
VRTX
$102B
|
DR
David Risinger
| $396.12 | $503 |
27%
upside
| Market Perform | 4 months ago |
|
34
NeoGenomics
NEO
$1.03B
|
PS
Puneet Souda
| $7.98 | $9 |
13%
upside
| Market Perform | 4 months ago |
|
35
Akebia Therapeutics
AKBA
$785M
|
RR
Roanna Ruiz
| $2.96 | $7 |
136%
upside
| Outperform | 4 months ago |
|
36
Spyre Therapeutics
SYRE
$1.03B
|
FK
Faisal Khurshid
| $17 | $45 |
165%
upside
| Outperform | 5 months ago |
|
37
Compass Therapeutics
CMPX
$590M
|
AB
Andrew Berens
| $3.44 | $6 |
74%
upside
| Outperform | 5 months ago |
|
38
AirSculpt Technologies
AIRS
$367M
|
WM
Whit Mayo
| $5.88 | $2.50 |
57%
downside
| Market Perform | 5 months ago |
|
39
Lexeo Therapeutics
LXEO
$271M
|
MF
Mani Foroohar
| $5.02 | $18 |
259%
upside
| Outperform | 5 months ago |
|
40
Medpace
MEDP
$13.7B
|
MC
Michael Cherny
| $486.98 | $330 |
32%
downside
| Market Perform | 5 months ago |
|
41
Nurix Therapeutics
NRIX
$758M
|
FK
Faisal Khurshid
| $9.91 | $16 |
61%
upside
| Market Perform | 5 months ago |
|
42
CorMedix
CRMD
$926M
|
RR
Roanna Ruiz
| $12.40 | $18 |
45%
upside
| Outperform | 6 months ago |
|
43
Lexicon Pharmaceuticals
LXRX
$396M
|
RR
Roanna Ruiz
| $1.09 | $1 |
8%
downside
| Market Perform | 6 months ago |
|
44
Recursion Pharmaceuticals
RXRX
$2.01B
|
MF
Mani Foroohar
| $4.61 | $6 |
30%
upside
| Market Perform | 6 months ago |
|
45
Hims & Hers Health
HIMS
$10.9B
|
MC
Michael Cherny
| $48.41 | $40 |
17%
downside
| Market Perform | 6 months ago |
|
|
MAZE
46
Maze Therapeutics, Inc. Common Stock
MAZE
$696M
|
JS
Joseph Schwartz
| $15.88 | $28 |
76%
upside
| Outperform | 6 months ago |
|
|
BBNX
47
Beta Bionics, Inc. Common Stock
BBNX
$878M
|
MK
Mike Kratky
| $20.20 | $28 |
39%
upside
| Outperform | 6 months ago |
|
|
ATYR
48
aTyr Pharma
ATYR
$550M
|
FK
Faisal Khurshid
| $5.61 | $16 |
185%
upside
| Outperform | 6 months ago |
|
49
Genmab
GMAB
$16.9B
|
JC
Jonathan Chang
| $27.54 | $27 |
2%
downside
| Outperform | 6 months ago |
|
50
10x Genomics
TXG
$1.74B
|
MK
Mike Kratky
| $13.96 | $12 |
14%
downside
| Market Perform | 6 months ago |
|